{{Rsnum
|rsid=17636071
|Gene=SLC9A9
|Chromosome=3
|position=143286187
|Orientation=plus
|GMAF=0.02158
|Gene_s=SLC9A9
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 14.2 | 85.8
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.9 | 99.1
| GIH | 1.0 | 10.9 | 88.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 6.9 | 93.1
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 9.8 | 90.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23374588
  |Trait=Response to cholinesterase inhibitors in Alzheimer's disease
  |Title=Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.
  |RiskAllele=G
  |Pval=2E-6
  |OR=4.74
  |ORtxt=[NR] unit decrease
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}